Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.20	37.15	43.81
Graham Fair Price	-16.80	21.93	26.36
PEG	21.58	-0.03	0.02
Price/Book	-19.04	1.51	1.86
Price/Cash Flow	77.73	-69.06	-310.08
Prices/Earnings	29.73	4.68	-3.60
Price/Sales	-19.20	8.16	10.10
Price/FCF	77.73	-69.06	-310.08
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	32.93	0.26	0.20
Operating Margin	20.08	0.24	0.20
ROA	-26.57	0.01	-0.02
ROE	-0.13	0.08	-37.59
ROIC	< 0.005	0.01	35.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.12	0.20	-38.46
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.87	0.27	-69.32
EPS QOQ	-1.55	1.66	6.71
FCF QOQ	-1.34	-2.83	-111.55
Revenue QOQ	0.14	0.06	-60.84
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.84	2.93	-57.16
Days Sales Outstanding (DSO)	174.93	59.28	-66.11
Inventory Turnover	13.15	30.70	133.42
Debt/Capitalization	0.74	0.70	-4.26
Quick Ratio	0.34	0.22	-37.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.47	16.29	5.32
Cash	2.12	2.13	0.63
Capex	-1.37	-1.04	23.76
Free Cash Flow	-0.09	-0.36	-282.90
Revenue	2.85	3.01	5.54
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.40	0.39	-1.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	26.04	22.34	-14.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating